Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5V7XP
|
|||
| Drug Name |
Delolimogene mupadenorepvec
|
|||
| Synonyms |
LOAd703
Click to Show/Hide
|
|||
| Drug Type |
Oncolytic virus
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1/2 | [1] | |
| Pancreatic cancer [ICD-11: 2C10; ICD-9: 157] | Phase 1/2 | [2] | ||
| Company |
Lokon Pharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04123470) A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02705196) Phase I/IIa Trial Evaluating Safety of LOAd703, an Armed Oncolytic Adenovirus for Pancreatic Cancer. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.